Sagent Pharmaceuticals Announces U.S. FDA Approval Of Azithromycin For Injection (Medical News Today)
Sagent Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, announced U.S. Food and Drug Administration (FDA) approval of azithromycin for injection, a semi-synthetic, macrolide antibiotic that is used to treat a wide variety of bacterial infections. Sagent will offer azithromycin in a 500 mg vial for intravenous use.

FDA Approves Abiomed's New AB Portable Driver; Providing Patient Transport, Mobility and Ambulation without ... (Business Wire via Yahoo! Finance)
DANVERS, Mass.----Abiomed, Inc. , a leading provider of heart recovery products designed to recover hearts and eliminate in-hospital deaths from heart attacks and high risk percutaneous coronary interventions , today announced U.S.